Similar Articles
471 Loco-regional treatment of hepatocellular carcinoma: Role of contrast-enhanced ultrasonography
472 Functions of three ubiquitin-conjugating enzyme 2 genes in hepatocellular carcinoma diagnosis and prognosis
473 Impact of COVID-19 pandemic on clinicopathological features of transplant recipients with hepatocellular carcinoma: A case-control study
474 Successful treatment in one myelodysplastic syndrome patient with primary thrombocytopenia and secondary deep vein thrombosis: A case report
475 Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics
476 Solute carrier family 2 members 1 and 2 as prognostic biomarkers in hepatocellular carcinoma associated with immune infiltration
477 Is there a role for liver transplantation in the treatment of hepatocellular carcinoma in non-cirrhotic liver?
478 Recurrence of infectious mononucleosis in adults after remission for 3 years: A case report
479 Mesentery solitary fibrous tumor with postoperative recurrence and sarcomatosis: A case report and review of literature
480 Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA